Skip to main content
Equibles

SOPH · SOPHiA GENETICS SA

Track SOPH — free

Use SOPH with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$8.09 -0.21 (-2.53%) At close · Sep 4
Rebalance outlook locked
Market Cap
$688.68M
Shares
85.13M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$8.09 Open$8.24 Day$8.06–8.30 52W close$3.12–8.92 Avg vol 30d515K Short int931K · 1.1% float · 1.7d Short vol62% Last earningsAug 4, 2026 DataJul 2021–Sep 2026

Up next

Next earnings call
Nov 3, 2026 Est · unconfirmed · in 8 wks

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$69.69M
Trailing 12 months
Net income (TTM)
−$73.39M
Trailing 12 months
Revenue growth YoY
+15.9%
Year over year
Operating margin
-96.6%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
-5.6%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+2.7%
Year over year · more shares
Price change (1Y)
+137.2%
Trailing year
Short interest
1.1%
Latest settlement · 1.7 days to cover
View all 114 metrics

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Buy Momentum Very Strong Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 14.5 · calm Equity put/call 0.58
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +51%
above
Price vs 50-day avg +19%
above
RSI (14) 56
neutral
MACD trend Negative
52-week position 86%
near high
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Strong
1-month return +5%
trailing
6-month return +65%
trailing
YTD return +73%
this year
Relative strength +50%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $7 › 200d $5 — 50d above 200d
Institutional flow Accumulating
+44% holders QoQ · +26 funds added
Insider flow Distributing
Net -$1.1K over 90 days · 100% sells
Short interest Rising
1.09% of float · ▲ +21.1% MoM · 1.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
72 holders — near 3-yr high, broad support
Squeeze score 53
elevated · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 70%
annualized · 1-yr
Max drawdown −26%
past year
ATR 5.9%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Prior guidance period ended · from the Earnings Call filed Sep 30, 2021
Full-year revenue · full year 2021 at least $40M

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy
1 · 3 · 3
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+51% Bullish
Price vs 50-day avg
+19% Bullish
RSI (14)
56 Neutral
MACD trend
Negative Bearish
52-week position
86% Bullish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $7 › 200d $5 — 50d above 200d
Institutional flow Accumulating
+44% holders QoQ · +26 funds added
Insider flow Distributing
Net -$1.1K over 90 days · 100% sells
Short interest Rising
1.09% of float · ▲ +21.1% MoM · 1.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
72 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $3 Now $8 · 86% Range high $9
vs 200-day avg +51% vs 50-day avg +19%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Health Information Services — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
SOPH
SOPHiA GENETICS SA
this stock
$688.68M +73.2% — — 1.1%
VEEV
Veeva Systems Inc
 $44.54B +23.2% +28.1% 45.0 3.6%
PMDIY
Pro Medicus Ltd./ADR
 $13.01B -25.0% — — 0.0%
BTSG
BrightSpring Health Services, Inc.
 $12.02B +62.2% +28.2% 36.8 4.5%
TEM
Tempus AI, Inc.
 $11.66B +9.4% +83.4% — 16.6%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
72
% held
43.8%
Net QoQ
+12.9M sh
Top holder
GENERATION INVESTMENT MAN…
Held Float
View
Held by Funds
Fund positions
3
View
Short & Settlement
Short Interest Rising
Shares short
930.7K
Days to cover
1.7d
Change
+162.4K sh
View
Short Volume
Short vol %
62%
As of
Sep 4, 2026
Short Total
View
Fails to Deliver
FTD shares
22.0K
Value
$167.7K
As of
Aug 14, 2026
View
Off-Exchange
Off-exchange %
38.1%
Week of
Jul 27, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$1.1K
Buyers / Sellers
0 / 1
Buyers Sellers
View
Filings
SEC Filings
Latest
6-K
Filed
Aug 4, 2026
This year
13
View
Proposed Sales
Value
$119.4K
Shares
14.0K
Filed
Aug 27, 2026
View
Earnings & Events
Earnings Calls
Last call
Aug 4, 2026
View

Performance

5D 20D 120D MTD YTD
SOPH -0.6% +4.9% +64.8% -3.7% +73.2%
SPY +0.1% -0.4% +15.1% +0.4% +12.9%
vs SPY -0.7% +5.3% +49.7% -4.1% +60.3%
Key facts CIK 1840706 CUSIP H82027105 13F (30d) 46 filings 46 filers Visit website Investor relations